Kim et al., 2019 - Google Patents

Multivalent traptavidin–DNA conjugates for the programmable assembly of nanostructures

Kim et al., 2019

Document ID
12387306471551030121
Author
Kim Y
Bang Y
Lee A
Song Y
Publication year
Publication venue
ACS nano

External Links

Snippet

Here, we explore the extended utility of two important functional biomolecules, DNA and protein, by hybridizing them through avidin–biotin conjugation. We report a simple yet scalable technique of successive magnetic separations to synthesize traptavidin–DNA …
Continue reading at pubs.acs.org (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
    • A61K47/48769—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form
    • A61K47/48853—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form the form being a particulate, powder, adsorbate, bead, sphere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/543—Immunoassay; Biospecific binding assay with an insoluble carrier for immobilising immunochemicals

Similar Documents

Publication Publication Date Title
Ge et al. Concept and development of framework nucleic acids
Kim et al. Multivalent traptavidin–DNA conjugates for the programmable assembly of nanostructures
Xu et al. Functional nucleic acid nanomaterials: development, properties, and applications
Nagamune Biomolecular engineering for nanobio/bionanotechnology
Daems et al. Three-dimensional DNA origami as programmable anchoring points for bioreceptors in fiber optic surface plasmon resonance biosensing
Kim et al. Reversible regulation of enzyme activity by pH-responsive encapsulation in DNA nanocages
Wang et al. Bioapplications of DNA nanotechnology at the solid–liquid interface
Shen et al. DNA origami nanophotonics and plasmonics at interfaces
Wu et al. Building a multifunctional aptamer-based DNA nanoassembly for targeted cancer therapy
Wang et al. Engineering DNA self-assemblies as templates for functional nanostructures
Shaw et al. Purification of functionalized DNA origami nanostructures
Stephanopoulos et al. Immobilization and one-dimensional arrangement of virus capsids with nanoscale precision using DNA origami
Giljohann et al. Gene regulation with polyvalent siRNA− nanoparticle conjugates
Avvakumova et al. Biotechnological approaches toward nanoparticle biofunctionalization
Mathur et al. Analyzing DNA nanotechnology: a call to arms for the analytical chemistry community
Fu et al. Aptamer-functionalized DNA nanostructures for biological applications
Guo et al. Diagnosis–Therapy integrative systems based on magnetic RNA nanoflowers for Co-drug delivery and targeted therapy
Huang et al. Encoding fluorescence anisotropic barcodes with DNA frameworks
Knappe et al. In situ covalent functionalization of DNA origami virus-like particles
Shen et al. Fractal nanoplasmonic labels for supermultiplex imaging in single cells
Sun et al. Terminal deoxynucleotidyl transferase-catalyzed preparation of pH-responsive DNA nanocarriers for tumor-targeted drug delivery and therapy
Liu et al. Targeted intracellular controlled drug delivery and tumor therapy through in situ forming Ag nanogates on mesoporous silica nanocontainers
Li et al. Hierarchical assembly of super-DNA origami based on a flexible and covalent-bound branched DNA structure
Deka et al. Surface passivation improves the synthesis of highly stable and specific DNA-functionalized gold nanoparticles with variable DNA density
Rajwar et al. Designer, programmable 3D DNA nanodevices to probe biological systems